JP2001523106A - 真核遺伝子発現カセットおよびその使用 - Google Patents
真核遺伝子発現カセットおよびその使用Info
- Publication number
- JP2001523106A JP2001523106A JP54672198A JP54672198A JP2001523106A JP 2001523106 A JP2001523106 A JP 2001523106A JP 54672198 A JP54672198 A JP 54672198A JP 54672198 A JP54672198 A JP 54672198A JP 2001523106 A JP2001523106 A JP 2001523106A
- Authority
- JP
- Japan
- Prior art keywords
- expression cassette
- promoter
- expression
- virus strain
- muscle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knockout animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2465—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/40—Fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.機能し得る形で連結された(i)ミオシンL鎖エンハンサー1個、(ii)ミオシ ンH鎖プロモーターおよびウイルスプロモーターから選択されるプロモーター1 個ならびに(iii)目的のポリヌクレオチド配列1個を含む、発現カセット。 2.前記ミオシンL鎖エンハンサーがミオシンL鎖1/3エンハンサーである、請 求項1に記載の発現カセット。 3.前記ミオシンH鎖プロモーターが魚類ミオシンH鎖プロモーターである、請 求項1または2に記載の発現カセット。 4.前記魚類ミオシンH鎖プロモーターがコイFG2ミオシンH鎖プロモーターで ある、請求項3に記載の発現カセット。 5.前記ミオシンH鎖プロモーターが哺乳動物ミオシンH鎖プロモーターである 、請求項1または2に記載の発現カセット。 6.前記哺乳動物ミオシンH鎖プロモーターが末端切断型ウサギβ心臓ミオシン H鎖プロモーターである、請求項5に記載の発現カセット。 7.前記ウイルスプロモーターがサイトメガロウイルスプロモーターまたは単純 heルペスウイルスプロモーターである、請求項1〜6のいずれか1項に記載の発 現カセット。 8.前記目的のポリヌクレオチド配列が治療上有用なポリペプチドをコードする 、請求項1〜7のいずれか1項に記載の発現カセット。 9.前記ポリペプチドがαガラクトシダーゼである、請求項8に記載の発現カセ ット。 10.前記目的のポリヌクレオチドを真核細胞に送達するのに使用するための、請 求項1〜9のいずれか1項に記載の発現カセット。 11.前記真核細胞が鳥類、魚類または哺乳動物の筋細胞である、請求項10に記載 の発現カセット。 12.請求項1〜11のいずれか1項で定義された発現カセットを含む、核酸ベク ター。 13.前記発現カセットに隣接する鳥類、魚類または哺乳動物のゲノム配列をさら に含む、請求項12に記載のベクター。 14.前記発現カセットに隣接するウイルスのゲノム配列をさらに含む、請求項12 または13に記載のベクター。 15.請求項1〜11のいずれか1項で定義された発現カセットを含む、ウイルス株 16.請求項1〜11のいずれか1項で定義された発現カセットをウイルスのゲノム 中に導入することを含む、請求項15に記載のウイルス株を製造する方法。 17.請求項14で定義されたベクターとウイルスのゲノム間での相同組み換えによ り、請求項1〜11のいずれか1項で定義された発現カセットを該ウイルスのゲノ ム中に導入することを含む、請求項15に記載のウイルス株を製造する方法。 18.ヒトまたは動物体の治療方法に使用するための、請求項1〜11のいずれか1 項に記載の発現カセット、請求項12〜14のいずれか1項に記載のベクターまたは 請求項15に記載のウイルス株。 19.ファブリ病の治療において使用するための、請求項1〜11のいずれか1項に 記載の発現カセット、請求項12〜14のいずれか1項に記載のベクターまたは請求 項15に記載のウイルス株。 20.請求項1〜11のいずれか1項に記載の発現カセット、請求項12〜14のいずれ か1項に記載のベクターまたは請求項15に記載のウイルス株の、ファブリ病の治 療における使用。 21.製薬上許容される担体または希釈剤とともに、請求項1〜11のいずれか1項 に記載の発現カセット、請求項12〜14のいずれか1項に記載のベクターまたは請 求項15に記載のウイルス株を含む、医薬組成物。 22.治療を必要とするヒトまたは動物に、有効で非毒性の量の請求項21に記載の 医薬組成物を投与することを含む、ヒトまたは動物体の治療方法。 23.ファブリ病の治療のための、請求項22に記載の方法。 24.治療を必要とするヒトまたは動物の細胞中に、該細胞中で治療用ポリペプチ ドをコードする異種遺伝子の有効な発現をもたらす量の、請求項1〜11のいずれ か1項に記載の発現カセット、請求項12〜14のいずれか1項に記載のベクターま たは請求項15に記載のウイルス株を導入することを含む、ヒトまたは動物の遺伝 子治療の効果をあげる方法。 25.前記目的のポリヌクレオチドが1以上のエピトープを含むポリペプチドをコ ードする、請求項1〜7のいずれか1項に記載の発現カセット。 26.前記ポリペプチドが病原生物由来である、請求項25に記載の発現カセット。 27.請求項25または26に記載の発現カセットを含むベクター。 28.請求項25または26に記載の発現カセットを含むウイルス株。 29.鳥類、魚類または哺乳動物の予防接種法に使用するための、請求項25若しく は26に記載の発現カセット、請求項27に記載のベクターまたは請求項28に記載の ウイルス株。 30.製薬上許容される担体または希釈剤とともに、請求項25若しくは26に記載の 発現カセット、請求項27に記載のベクターまたは請求項28に記載のウイルス株を 含む、ワクチン。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9708526.0 | 1997-04-25 | ||
GBGB9708526.0A GB9708526D0 (en) | 1997-04-25 | 1997-04-25 | Eukaryotic gene expression cassette and uses thereof |
PCT/GB1998/001198 WO1998049333A2 (en) | 1997-04-25 | 1998-04-24 | Eukaryotic gene expression cassette and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001523106A true JP2001523106A (ja) | 2001-11-20 |
Family
ID=10811432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54672198A Pending JP2001523106A (ja) | 1997-04-25 | 1998-04-24 | 真核遺伝子発現カセットおよびその使用 |
Country Status (5)
Country | Link |
---|---|
US (2) | US20020025577A1 (ja) |
EP (1) | EP0977879A2 (ja) |
JP (1) | JP2001523106A (ja) |
GB (1) | GB9708526D0 (ja) |
WO (1) | WO1998049333A2 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005116194A1 (ja) * | 2004-05-25 | 2005-12-08 | Riken | 試験管内筋繊維形成のための筋芽細胞又は筋芽細胞様細胞培養法 |
JP2009513106A (ja) | 2003-07-08 | 2009-04-02 | アキシオジェネシス エージー | 細胞分化のためのマーカーとしての分泌タンパク質 |
US9726662B2 (en) | 2004-05-11 | 2017-08-08 | Axiogenesis Ag | Assay for drug discovery based on in vitro differentiated cells |
US9945840B2 (en) | 2004-04-07 | 2018-04-17 | Axiogenesis Ag | Non-invasive, in vitro functional tissue assay systems |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1658857A1 (en) * | 1997-10-29 | 2006-05-24 | Genzyme Corporation | Compositions and methods for treating lysosomal storage disease |
ATE333893T1 (de) * | 1997-10-29 | 2006-08-15 | Genzyme Corp | Gentherapie für gaucher-krankheit |
WO1999054491A1 (en) * | 1998-04-20 | 1999-10-28 | Children's Hospital Medical Center | Use of murine myosin heavy chain promoters for gene therapy and production of transgenics |
FR2792336B1 (fr) * | 1999-04-15 | 2003-07-11 | Pasteur Institut | Cassette de regulation de l'expression d'un acide nucleique heterologue dans une cellule eucaryote, en particulier musculaire |
US9321997B2 (en) | 2003-06-20 | 2016-04-26 | Axiogenesis Ag | Tissue modeling in embryonic stem (ES) cell system |
US20050244377A1 (en) * | 2003-12-24 | 2005-11-03 | Daniel Sigg | Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel |
US8859273B2 (en) * | 2003-12-24 | 2014-10-14 | Medtronic, Inc. | Methods of using HCN genes to treat cardiac arrhythmias |
GB201508025D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Fabry disease gene therapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5433946A (en) * | 1991-10-11 | 1995-07-18 | Health Research Inc. | Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases |
US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
GB9310441D0 (en) * | 1993-05-20 | 1993-07-07 | Royal Free Hosp School Med | Gene therapy |
AU2002211524B2 (en) * | 2000-10-04 | 2007-03-22 | The Trustees Of The University Of Pennsylvania | Highly expressible genes |
-
1997
- 1997-04-25 GB GBGB9708526.0A patent/GB9708526D0/en active Pending
-
1998
- 1998-04-24 WO PCT/GB1998/001198 patent/WO1998049333A2/en active Application Filing
- 1998-04-24 JP JP54672198A patent/JP2001523106A/ja active Pending
- 1998-04-24 EP EP98917462A patent/EP0977879A2/en not_active Withdrawn
- 1998-04-24 US US09/403,707 patent/US20020025577A1/en not_active Abandoned
-
2001
- 2001-12-05 US US10/005,131 patent/US20030008836A1/en not_active Abandoned
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009513106A (ja) | 2003-07-08 | 2009-04-02 | アキシオジェネシス エージー | 細胞分化のためのマーカーとしての分泌タンパク質 |
US9945840B2 (en) | 2004-04-07 | 2018-04-17 | Axiogenesis Ag | Non-invasive, in vitro functional tissue assay systems |
US11835433B2 (en) | 2004-04-07 | 2023-12-05 | Evotec International Gmbh | Non-invasive, in vitro functional tissue assay systems |
US9726662B2 (en) | 2004-05-11 | 2017-08-08 | Axiogenesis Ag | Assay for drug discovery based on in vitro differentiated cells |
WO2005116194A1 (ja) * | 2004-05-25 | 2005-12-08 | Riken | 試験管内筋繊維形成のための筋芽細胞又は筋芽細胞様細胞培養法 |
Also Published As
Publication number | Publication date |
---|---|
GB9708526D0 (en) | 1997-06-18 |
WO1998049333A3 (en) | 1999-01-28 |
WO1998049333A2 (en) | 1998-11-05 |
EP0977879A2 (en) | 2000-02-09 |
US20030008836A1 (en) | 2003-01-09 |
US20020025577A1 (en) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU734290B2 (en) | Compositions and methods for treating lysosomal storage disease | |
US8883756B2 (en) | SDF-1 delivery for treating ischemic tissue | |
JP4987205B2 (ja) | 遺伝子送達用核酸製剤および使用方法 | |
JPH10503469A (ja) | 緻密にした核酸および細胞へのデリバリ | |
JPH04504125A (ja) | 脊椎動物における外因性ポリヌクレオチド配列の発現 | |
JP2001523106A (ja) | 真核遺伝子発現カセットおよびその使用 | |
CN113584043B (zh) | 用于治疗视网膜疾病和癌症的转基因表达盒 | |
CN113563430B (zh) | 用于治疗眼部疾病的基因递送系统及其应用 | |
CN113480615B (zh) | 高视网膜亲和性的新型腺相关病毒衣壳蛋白及其应用 | |
KR20220107243A (ko) | Apoe 유전자 요법 | |
US20040224409A1 (en) | Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF) | |
US6706694B1 (en) | Expression of exogenous polynucleotide sequences in a vertebrate | |
US20020065213A1 (en) | Methods and compositions for nonviral gene delivery | |
US8445454B2 (en) | Use on minicircle vectors for cardiac gene therapy | |
US20230024301A1 (en) | Treatment of diseases caused by frame shift mutations | |
KR20220034833A (ko) | 현성형 변이 유전자에 유래하는 질환의 치료제 | |
CN112813063A (zh) | 脂代谢紊乱动物模型构建以及利用aav-crispr/cas9的修复 | |
US20020031493A1 (en) | Recombinant adenoviruses coding for glial-derived cell neurotrophic factor (gdnf) | |
AU703793B2 (en) | Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF) | |
DE69531678T2 (de) | Rekombinatie viren,ihre herstellung und ihre verwendung in der gentherapie | |
JP5323293B2 (ja) | 生物学的因子の生産および遺伝的に改変されたセルトーリ細胞を用いる免疫学的特権環境の創製 | |
CN111154757B (zh) | Aggf1基因的3’-UTR序列及其应用 | |
Massaro | Intravenously administered gene therapy for neuronopathic Gaucher disease | |
KR20160005021A (ko) | 허혈 조직 처리를 위한 sdf-1의 전달 | |
TW202334194A (zh) | 用於表現因子ix以便治療b型血友病的組成物及方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050421 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071204 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080226 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080414 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080604 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081111 |